Cyclerion Therapeutics
CYCN
CYCN
50 hedge funds and large institutions have $25.6M invested in Cyclerion Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
41% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 17
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
50
Holding in Top 10
–
Calls
$400K
Puts
$2K
Top Buyers
1 | +$128K | |
2 | +$105K | |
3 | +$91.5K | |
4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$28K |
5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$27.6K |
Top Sellers
1 | -$340K | |
2 | -$160K | |
3 | -$129K | |
4 |
Two Sigma Investments
New York
|
-$106K |
5 |
Millennium Management
New York
|
-$105K |